These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15451807)

  • 1. A new HOPE for aldosterone blockade?
    Pitt B
    Circulation; 2004 Sep; 110(13):1714-6. PubMed ID: 15451807
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy.
    Touyz RM; Callera GE
    Circ Res; 2009 Jan; 104(1):9-11. PubMed ID: 19118282
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular actions of aldosterone.
    Briet M; Schiffrin EL
    J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symposium on the etiology of hypertension--summarizing studies in 20th century. 5. Renin-angiotensin system and hypertension.
    Fujita T
    Intern Med; 2001 Feb; 40(2):156-8. PubMed ID: 11300153
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II: a devious activator of mineralocorticoid receptor-dependent gene expression.
    Blaxall BC; Miano JM; Berk BC
    Circ Res; 2005 Apr; 96(6):610-1. PubMed ID: 15802618
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
    Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
    Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
    Tsuji H; Wang W; Sunil J; Shimizu N; Yoshimura K; Uemura H; Peck AB; Khan SR
    World J Urol; 2016 Jan; 34(1):89-95. PubMed ID: 25981400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
    Gabor A; Leenen FH
    Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of aldosterone receptor blocker to dual renin-angiotensin-aldosterone blockade leads to limitation of tubulointerstitial injury of kidney.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Kidney Int; 2007 Nov; 72(9):1164-5. PubMed ID: 17943159
    [No Abstract]   [Full Text] [Related]  

  • 15. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing renal disease progression: can complete renin-angiotensin-aldosterone blockade work?
    Schreiber MJ
    Cleve Clin J Med; 2008 Oct; 75(10):699-700, 703-4. PubMed ID: 18939385
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aldosterone in heart failure].
    Yoshimura M
    Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):377-80. PubMed ID: 16462087
    [No Abstract]   [Full Text] [Related]  

  • 19. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
    Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
    Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms responsible for the renoprotective effects of renin-angiotensin inhibitors].
    Nishiyama A
    Yakugaku Zasshi; 2012; 132(4):455-9. PubMed ID: 22465922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.